Sorority rush gets Ozempic makeover as some college women resort to weight-loss injections
RIGHT SO CONTEXT FIRST BECAUSE IT MATTERS AND EVERYONE THINKS GLP-1 MEDICATIONS ARE ONLY FOR OLDER PATIENTS TREATING DIABETES BUT THEY ARE GROWING FASTEST AMONG ADULTS UNDER FORTY AND HAVE OFFICIALLY HIT COLLEGE CAMPUSES AND SORORITY RUSH WHICH IS GENUINELY TERRIFYING BECAUSE STUDENTS ARE REPORTEDLY TAKING OZEMPIC AND COMPOUNDED VERSIONS JUST TO SURVIVE RECRUITMENT AND CHASE AN EXTREMELY THIN BEAUTY IDEAL AND THE THING IS A JAMA STUDY FOUND OVER ONE HUNDRED AND SIXTY-TWO THOUSAND YOUNG ADULTS AGES EIGHTEEN TO TWENTY-FIVE WERE PRESCRIBED THEM IN TWENTY TWENTY-THREE WITH OVER SEVENTY-SIX PERCENT BEING WOMEN AND NOW A SURVEY SHOWS HIGH SCHOOLERS ARE USING THEM WITHOUT PRESCRIPTIONS TOO AND EXPERTS ARE WARNING THAT A GENUINE MEDICAL INTERVENTION HAS BEEN HIJACKED AS A COSMETIC SHORTCUT BY TWENTY-YEAR-OLDS WITH NORMAL BMIS COMPARING THEMSELVES ON SOCIAL MEDIA.
OK THIS IS THE ONE I WAS TELLING YOU ABOUT AND THE DETAIL THAT MADE ME PUT MY DRINK DOWN IS THAT TWO PERCENT OF KIDS IN EIGHTH TENTH AND TWELFTH GRADE ARE REPORTEDLY TAKING GLP-ONE DRUGS WITHOUT EVEN HAVING A PRESCRIPTION AND THE THING IS IT HAS SPREAD RIGHT ONTO COLLEGE CAMPUSES WHERE NINETEEN-YEAR-OLDS WITH COMPLETELY NORMAL BODY WEIGHT ARE INJECTING COMPOUNDED SEMAGLUTIDE AND TIRZEPATIDE JUST TO SURVIVE SORORITY RUSH AND MEET AN EXTREMELY THIN BEAUTY STANDARD WHICH IS WILD BECAUSE AN EXPERT NAMED JAY CAMPBELL SAYS A GENUINE MEDICAL INTERVENTION FOR METABOLIC ILLNESS HAS BEEN HIJACKED AS AN AESTHETIC SHORTCUT IN A SYRINGE AND ONE FORMER RECRUITER SAID PEOPLE ACT LIKE NOBODY HAS AN EXCUSE NOT TO BE THIN NOW AND IT SPREADS ON INSTAGRAM BECAUSE SOMEONE DROPS FIFTEEN POUNDS IN SIX WEEKS. OK I AM GOING TO GO SHOUT AT A WALL.
College students are increasingly using GLP-1 weight-loss medications like Ozempic to prepare for sorority recruitment amid rising social media pressures.
Named in this and it is not fair or not accurate? Write to us — we correct or remove within a few days.